To determine the clinical relevance of IGF2BP2 in CRPC, we analyzed the mRNA expression data for prostate cancer patients available in the GDC Data Portal (https://portal.gdc.cancer.gov/). The gene discussed is IGF2BP2; the disease is prostate carcinoma.